SHPH — Shuttle Pharmaceuticals Holdings Balance Sheet
0.000.00%
- $1.94m
- $0.89m
Annual balance sheet for Shuttle Pharmaceuticals Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.117 | 0.505 | 8.42 | 5.46 | 1.92 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.211 | 0 | — | 0.015 | 0 |
Prepaid Expenses | |||||
Total Current Assets | 0.341 | 0.51 | 8.58 | 5.59 | 2.21 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.196 | 0.136 | 0.069 | 0.359 | 0.295 |
Other Long Term Assets | |||||
Total Assets | 0.544 | 0.652 | 8.65 | 5.95 | 2.51 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.1 | 2.22 | 0.976 | 1.04 | 1.53 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.23 | 2.28 | 0.976 | 1.9 | 1.8 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -1.69 | -1.63 | 7.68 | 4.06 | 0.709 |
Total Liabilities & Shareholders' Equity | 0.544 | 0.652 | 8.65 | 5.95 | 2.51 |
Total Common Shares Outstanding |